Thornton and Ross, a prominent name in the pharmaceutical industry, is headquartered in GB and has established a strong presence across the UK and international markets. Founded in 1922, the company has a rich history marked by significant milestones, including the development of innovative healthcare solutions. Specialising in over-the-counter (OTC) medicines and healthcare products, Thornton and Ross is renowned for its commitment to quality and efficacy. Their core offerings include a diverse range of products, from pain relief to dermatological treatments, each designed to meet the specific needs of consumers. With a reputation for excellence, Thornton and Ross has secured a notable position in the market, consistently recognised for its contributions to public health and well-being. The company’s dedication to research and development ensures that it remains at the forefront of the industry, delivering unique solutions that enhance the lives of its customers.
How does Thornton And Ross's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Thornton And Ross's score of 26 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Thornton and Ross reported total carbon emissions of approximately 8,822,000 kg CO2e. This figure includes 1,523,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources. Notably, Scope 2 emissions were reported as zero, indicating no indirect emissions from purchased electricity, steam, heating, and cooling. The majority of their emissions stem from Scope 3, amounting to about 6,822,000 kg CO2e, which includes significant contributions from downstream transportation and distribution (approximately 3,733,000 kg CO2e) and upstream transportation and distribution (about 1,415,000 kg CO2e). Comparatively, in 2022, the total emissions were around 8,800,000 kg CO2e, with Scope 1 emissions at 1,531,000 kg CO2e and Scope 3 emissions at 6,232,000 kg CO2e. This indicates a slight increase in Scope 3 emissions in 2023. Despite these figures, Thornton and Ross have not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. Their commitment to reducing carbon emissions remains unclear, highlighting a potential area for improvement in transparency and accountability regarding climate action.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2022 | 2023 | |
---|---|---|
Scope 1 | 1,531,000 | 0,000,000 |
Scope 2 | 1,327,000 | - |
Scope 3 | 6,232,000 | 0,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Thornton And Ross is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.